Skip to content
Peptide research

BPC-157

Also known as Body Protection Compound-157
Category
Tissue Repair & Recovery
Administration routes
InjectableOral
Regulatory status
Not FDA-approved

What it is

A synthetic 15-amino-acid peptide widely used for recovery of tendons, ligaments, muscle, and the gut lining. The case rests almost entirely on animal studies. Human evidence is minimal, human safety data remain inadequate, and a theoretical tumor-growth concern (it promotes new blood-vessel formation) is unresolved. Most supply is unregulated product sold online, of uncertain purity.

Read Full record

Studied uses & evidence

Studied uses(8)

  • Tendon healing and repair

    Medium

    Accelerates tendon fibroblast outgrowth and cell survival under oxidative stress

  • Angiogenesis and vascular repair

    Medium

    Promotes new blood vessel formation through VEGFR2 activation

  • Gastrointestinal cytoprotection

    Medium

    Protective effects against gastric ulcers and intestinal damage

Evidence limits

Evidence Level
Preclinical

>95% evidence from animal studies. Human evidence includes three small full reports and older controlled studies available as meeting abstracts. Phase 2 RCT for hamstring strains began recruiting Feb 2026.

Benefits = confidence in the evidence: High · Medium · Low · Speculative (High requires human randomized trials for that specific benefit)

Cautions & risk summary

Do not use if

  • Active cancer or history of cancer

    High

    BPC-157 promotes angiogenesis (new blood vessel growth), which can feed tumor growth. Avoid with any active malignancy.

  • Active bleeding disorders

    Moderate

    May affect blood clotting through nitric oxide system modulation.

General cautions

  • Pregnancy or breastfeeding

    Absolute

    No human safety data. Effects on fetal development unknown.

  • Children under 18

    Absolute

    No pediatric safety data exists.

Risk summary(5)

Risks = level of concern: High · Moderate · Low · Theoretical

  • No large-scale human safety trials completed

    High
  • Theoretical cancer risk (promotes angiogenesis / VEGFR2 which tumors use)

    Theoretical
  • Human evidence limited to a few small, uncontrolled pilots / unpublished early-phase trials

    Low
  • Named on WADA's Prohibited List since 2022

    Moderate
  • Unregulated products sold online vary widely in quality

    High
Safety & interactions in Full record

Further reading

Read Full record

This is educational content compiled from published research, not medical advice. Always consult a licensed healthcare provider before using any peptide. Medical disclaimer

Compiled from published research indexed through March 2026.